S. MUOIO & CO. LLC - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
S. MUOIO & CO. LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$964,000
+31.3%
52,468
+31.2%
1.05%
+25.5%
Q3 2020$734,00040,0000.83%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q3 2023
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 40,000$734,0000.83%
WATER ISLAND CAPITAL LLC 133,286$2,444,0000.21%
Walleye Capital LLC 90,666$1,663,0000.18%
GLAZER CAPITAL, LLC 202,158$3,708,0000.18%
First Trust Capital Management L.P. 35,613$653,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 12,500$229,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$194,0000.15%
Olympiad Research LP 13,484$247,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.10%
Alpine Global Management, LLC 25,000$459,0000.10%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders